Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 4, 2010, Pages

  Dodd, Jodie M ^a   Crowther, Caroline A ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; MISOPROSTOL; OXYTOCIC AGENT;

CONGENITAL DISORDER; FEMALE; FETUS DEATH; HUMAN; INDUCED ABORTION; LABOR INDUCTION; METHODOLOGY; PREGNANCY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; CONGENITAL ABNORMALITIES; FEMALE; FETAL DEATH; HUMANS; LABOR, INDUCED; MISOPROSTOL; OXYTOCICS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 77952501585     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004901.pub2     Document Type: Review

References (72)

1. Akoury HA, Hannah ME, Chitayat D, Thomas M, Winsor E, Ferris LE, et al. Randomized controlled trial of misoprostol for second trimester pregnancy termination associated with fetal malformation. American Journal Obstetrics and Gynecology 2004;190(3):755-62. x-wiley/crsRef/7908655
2. Bebbington MW, Kent N, Lim K, Gagnon A, Delisle MF, Tessier F, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. American Journal Obstetrics and Gynecology 2002;187(4):853-7. x-wiley/crsRef/7908657
3. Behrashi M, Mahdian M. Vaginal versus oral misoprostol for second-trimester pregnancy termination: a randomized trial. Pakistan Journal of Biological Sciences 2008;11(21):2505-8. x-wiley/crsRef/7908659
4. Caliskan E, Dilbaz S, Doger E, Ozeren S, Dilbaz B. Randomized comparison of 3 misoprostol protocols for abortion induction at 13-20 weeks of gestation. Journal of Reproductive Medicine 2005;50(3):173-80. x-wiley/crsRef/7908661
5. Caliskan E, Doger E, Cakiroglu Y, Corakci A, Yucesoy I. Sublingual misoprostol 100 microgram versus 200 microgram for second trimester abortion: a randomised trial. European Journal of Contraception & Reproductive Health Care 2009;14(1):55-60. x-wiley/crsRef/7908663
6. Chittacharoen A, Herbutya Y, Punyavachira P. A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics and Gynecology 2003;101:70-3. x-wiley/crsRef/7908665
7. Dickinson JE, Godfrey M, Evans SF. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. Journal of Maternal-Fetal Medicine 1998;7:115-9. x-wiley/crsRef/7908667
8. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second trimester pregnancy termination. American Journal of Obstetrics and Gynecology 2002;186(3):470-4. x-wiley/crsRef/7908669
9. Dickinson JE, Evans SF. A comparison of oral misoprostol with vaginal misoprostol administration in second trimester pregnancy termination for fetal abnormality. Obstetrics & Gynecology 2003;101:1294-9. x-wiley/crsRef/7908671
10. Elhassan EM, Abubaker MS, Adam I. Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second-trimester fetal demise. International Journal of Gynecology & Obstetrics 2008;100(1):82-3. x-wiley/crsRef/7908673
11. Fadalla F, Mirghani OA, Adam I. Oral misoprostol vs vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second trimester. International Journal of Gynecology & Obstetrics 2004;86:52-3. x-wiley/crsRef/7908675
12. Feldman DM, Borgida AF, Rodis JF, Leo MV, Campbell WA. A randomized comparison of two regimens of misoprostol for second-trimester pregnancy termination. American Journal Obstetrics and Gynecology 2003;189:710-3. x-wiley/crsRef/7908677
13. Ghorab MN, El Helw BA. Second trimester termination of pregnancy by extra-amniotic prostaglandin F2alpha or endocervical misoprostol: a comparative study. Acta Obstetricia et Gynecologica Scandinavica 1998;77:429-32. x-wiley/crsRef/7908679
14. Gilbert A, Reid R. A randomised trial of oral versus vaginal administration of misoprostol for the purpose of mid-trimester termination of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 2001;41(4):407-10. x-wiley/crsRef/7908681
15. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2005;111:148-53. x-wiley/crsRef/7908683
16. Herabutya Y, O-Prasertsawat P. A comparison of intravaginal misoprostol with intracervical prostaglandin E2 gel for the management of dead fetus in utero. Thai Journal of Obstetrics and Gynaecology 1997; Vol. 9, issue 2:95-8. x-wiley/crsRef/7908685
17. Herabutya Y, Chanrachakul B, Punyavachira P. A randomised trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination. BJOG: an international journal of obstetrics and gynaecology 2005;112(9):1297-301. x-wiley/crsRef/7908687
18. Hidar S, Fekih M, Chaieb A, Bibi M, Mellouli R, Khairi H. Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea: a prospective randomized trial. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 2001;30(5):439-43. x-wiley/crsRef/7908689
19. Hidar S, Bouddebous M, Chaieb A, Jerbi M, Bibi M, Khairi H. Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13-29 weeks. Archives of Gynecology and Obstetrics 2005;273(3):157-60. x-wiley/crsRef/7908691
20. Jain JK, Mishell DR. A comparison of misoprostol with and without laminaria tents for induction of second-trimester abortion. American Journal of Obstetrics and Gynecology 1996;175:173-7. x-wiley/crsRef/7908693
21. Jain JK, Mishell DR. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination. Obstetrics & Gynecology 1999;93:571-5. x-wiley/crsRef/7908695
22. Jain JK, Mishell DR. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second trimester pregnancy. New England Journal of Medicine 1994;331:290-3. x-wiley/crsRef/7908697
23. Jansen NE, Pasker-De Jong PC, Zondervan HA. Mifepristone and misoprostol versus Dilapan and sulprostone for second trimester termination of pregnancy. Journal of Maternal-Fetal & Neonatal Medicine 2008;21(11):847-51. x-wiley/crsRef/7908699
24. Kara M, Ozden S, Eroglu M, Cetin A, Arioglu P. Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss. Italian Journal of Gynaecology & Obstetrics 1999;11:13-6. x-wiley/crsRef/7908701
25. Makhlouf AM, Al-Hussaini TK, Habib DM, Makarem MH. Second-trimester pregnancy termination: comparison of three different methods. Journal of Obstetrics and Gynaecology 2003;23:407-11. x-wiley/crsRef/7908703
26. Munthali J, Moodley J. The use of misoprostol for mid-trimester therapeutic termination of pregnancy. Tropical Doctor 2001;31(3):157-61. x-wiley/crsRef/7908705
27. Nakintu N. A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intra-uterine fetal death in Mulago Hospital, Uganda. African Health Sciences 2001;1(2):55-9. x-wiley/crsRef/7908707
28. Neto CM, Delbin AL, Do Val Junior R. Tocographic pattern caused by misoprostol. Revista Paulista de Medicina 1988;106(4):205-8. x-wiley/crsRef/7908709
29. Niromanesh S, Hashemi-Fesharaki M, Mosavi-Jarrahi A. Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology & Obstetrics 2005;89:276-7. x-wiley/crsRef/7908711
30. Nor Azlin MI, Abdullah HS, Zainul Rashid MR, Jamil MA. Misoprostol (alone) in second trimester terminations of pregnancy: as effective as Gemeprost?. Journal of Obstetrics and Gynaecology 2006;26(6):546-9. x-wiley/crsRef/7908713
31. Nuutila M, Toivonen J, Ylikorkala O, Halmesmaki E. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstetrics & Gynecology 1997;90(6):896-900. x-wiley/crsRef/7908715
32. Nyende L, Towobola OA, Mabina MH. Comparison of vaginal and oral misoprostol, for the induction of labour in women with intra-uterine foetal death. East African Medical Journal 2004;81(4):179-82. x-wiley/crsRef/7908717
33. Owen J, Hauth JC. Vaginal misoprostol vs concentrated oxytocin plus low-dose prostaglandin E2 for second trimester pregnancy termination. Journal of Maternal-Fetal Medicine 1999;81(4):179-82. x-wiley/crsRef/7908719
34. Perry KG, Rinehart BK, Terrone DA, Martin RW, May WL, Roberts WE. Second trimester uterine evacuation: a comparison of intra-amniotic (15-S)-15-methyl-prostaglandin F2alpha and intravaginal misoprostol. American Journal of Obstetrics and Gynecology 1999;181:1057-61. x-wiley/crsRef/7908721
35. Pongsatha S, Tongsong T. Intravaginal misoprostol for pregnancy termination. International Journal of Gynecology & Obstetrics 2004;87:176-7. x-wiley/crsRef/7908723
36. Ramsey PS, Savage K, Lincoln T, Owen J. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction. Obstetrics & Gynecology 2004;104(1):138-45. x-wiley/crsRef/7908725
37. Su L-L, Biswas A, Choolani M, Kalaichelvan V, Singh K. A prospective randomized comparison of vaginal misoprostol versus intra-amniotic prostaglandins for midtrimester termination of pregnancy. American Journal of Obstetrics and Gynecology 2005;193:1410-4. x-wiley/crsRef/7908727
38. Zuo WL, Wang P, Wu BS. A randomized comparison of misoprostol and carprost for termination of second trimester pregnancy. Chinese Journal of Clinical Pharmacology 1998;14(4):197-200. x-wiley/crsRef/7908729
39. Ayudhaya OP, Herabutya Y, Chanrachakul B, Ayuthaya NI, O-Prasertsawat P. A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand 2006;89(Suppl 4):S5-S10. x-wiley/crsRef/7908731
40. Biswas SC, Dey R, Jana R, Chattopadhyay N. Comparative study of intravaginal misoprostol and extra amniotic ethacridine lactate instillation for mid trimester pregnancy termination. Journal of Obstetrics and Gynaecology of India 2007;57(3):211-3. x-wiley/crsRef/7908733
41. El-Refaey H, Templeton A. Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomized comparison between two misoprostol regimens. Human Reproduction 1995;10(2):475-8. x-wiley/crsRef/7908735
42. Eng NS, Guan AC. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology 1997;37(3):331-4. x-wiley/crsRef/7908737
43. Gonzalez JA, Carlan SJ, Alverson MW. Outpatient second trimester pregnancy termination. Contraception 2001;63(2):89-93. x-wiley/crsRef/7908739
44. Guix C, Palacio M, Figueras F, Bennasar M, Zamora L, Coll O, et al. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination. Fetal Diagnosis and Therapy 2005;20(6):544-8. x-wiley/crsRef/7908741
45. Herabutya Y, Chanrachakul B, Punyavachira P. Second trimester pregnancy termination: A comparison of 600 and 800 micrograms of intravaginal misoprostol. Journal of Obstetrics and Gynaecology Research 2001;27(3):125-8. x-wiley/crsRef/7908743
46. Marquette GP, Skoll MA, Dontigny L. A randomized trial comparing oral misoprostol with intra-amniotic prostaglandin f2alpha for second trimester terminations. Journal of Obstetrics & Gynaecology Canada: JOGC 2005;27(11):1013-8. x-wiley/crsRef/7908745
47. Nigam A, Singh VK, Prakash A. Vaginal vs. oral misoprostol for mid-trimester abortion. International Journal of Gynecology & Obstetrics 2006;92(3):270-1. x-wiley/crsRef/7908747
48. Saha S, Bal R, Ghosh S, Krishnamurthy P. Medical abortion in late second trimester--a comparative study with misoprostol through vaginal versus oral followed by vaginal route. Journal of the Indian Medical Association 2006;104(2):81-2, 84. x-wiley/crsRef/7908749
49. Yapar EG, Senoz S, Urkutur M, Batioglu S, Gokmen O. Second trimester pregnancy termination including fetal death: comparison of five different methods. European Journal of Obstetrics & Gynecology and Reproductive Biology 1996;69:97-102. x-wiley/crsRef/7908751
50. Abdel Fattah IH. PGE1 analogue for the induction of midtrimester abortion in cases of intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica Supplement 1997;76(167:2):26. x-wiley/crsRef/7908753
51. Agrawal S, Rath SK. Misoprostol for second trimester medical abortion - a comparison of three routes of administration [abstract]. 49th All India Congress of Obstetrics and Gynaecology; 2006 Jan 6-9; Cochin, Kerala State, India. 2006:47. x-wiley/crsRef/7908755
52. Nuthalapaty F, Ramsey P, Biggio J, Owen J. Comparative efficacy of high dose vaginal misoprostol for mid-trimester labor induction [abstract]. American Journal of Obstetrics and Gynecology 2004;191(6 Suppl 1):S73. x-wiley/crsRef/7908757
53. Roy G, Ferreira E, Hudon L, Marquette G. The efficacy of oral versus vaginal misoprostol for second-trimester termination of pregnancy: a double-blind, randomized, placebo controlled trial [abstract]. American Journal of Obstetrics and Gynecology 2003;189(6 Suppl 1):S70. x-wiley/crsRef/7908759
54. Surita FGC. Misoprostol versus laminaria for cervical ripening in intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica Supplement 1997;76(167:2):32. x-wiley/crsRef/7908761
55. Alfirevic Z, Weeks A. Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD001338.pub2]
56. Boulvain M, Kelly A, Lohse C, Stan C, Irion O. Mechanical methods for induction of labour. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD001233]
57. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Davey Smith G, Altman DG editor(s). Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group, 2001.
58. French L. Oral prostaglandin E2 for induction of labour. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD003098]
59. Gulmezoglu AM, Forna F, Villar J, Hofmeyr GJ. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews 2007, Issue 3. [DOI: 10.1002/14651858.CD000494.pub3]
60. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
61. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
62. Hofmeyr GJ, Gulmezoglu AM. Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000941]
63. Hutton E, Mozurkewich E. Extra-amniotic prostaglandin for induction of labour. Cochrane Database of Systematic Reviews 2001, Issue 2. [DOI: 10.1002/14651858.CD003092]
64. Kelly AJ, Tan B. Intravenous oxytocin alone for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews 2001, Issue 3. [DOI: 10.1002/14651858.CD003246]
65. Kelly AJ, Kavanagh J, Thomas J. Vaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003101]
66. Luckas M, Bricker L. Intravenous prostaglandin for induction of labour. Cochrane Database of Systematic Reviews 2000, Issue 4. [DOI: 10.1002/14651858.CD002864]
67. Mackenzie IZ. Labor induction including pregnancy termination for fetal anomaly. In: James DK, Steer PJ, Weiner CP, Gonik G editor(s). High risk pregnancy management options. Second Edition. London: WB Saunders, 1999.
68. Mariani-Neto C, Leao EJ, Kenj G, De Aquino MM. Use of misoprostol for induction of labour in stillbirths. Revista Paulista de Medicina 1987;105:325-8.
69. Medema S, Wildschut H, Van Gemund N, Scherjon S. Medical methods for mid-trimester termination of pregnancy. Cochrane Database of Systematic Reviews 2005, Issue 2. [DOI: 10.1002/14651858.CD005216]
70. Neilson JP, Hickey M, Vazquez JC. Medical treatment for early fetal death (less than 24 weeks). Cochrane Database of Systematic Reviews 2006, Issue 3. [DOI: 10.1002/14651858.CD002253.pub3]
71. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.0. Copenhage: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
72. Weiner CP. Fetal Death. In: James DK, Steer PJ, Weiner CP, Gonik B editor(s). High risk pregnancy management options. Second Edition. London: WB Saunders, 1999.